Atlas Trials

A Pilot Study of Pre- and Post-surgery Chemotherapy With mFOLFIRINOX in Localized, Resectable Pancreatic Adenocarcinoma

Clinical trial NCT01660711 · COMPLETED

Trial details

NCT number
NCT01660711
Sponsor
Endeavor Health
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Pancreatic Adenocarcinoma
Start date
2012-07-01
Primary completion
2018-08-22
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.